Cleveland.com: Biotech startup Lamassu, Cleveland Clinic aim to treat rare cancers with just three pills a month

11/05/2024

CLEVELAND, Ohio — A biotech startup from North Carolina thinks Cleveland is where it will develop how to treat rare cancers with just three pills a month.

If effective, Lamassu Biotech’s innovative gene therapy could eliminate the need for surgery or chemotherapy for some types of hard-to-treat cancer, said CEO Dr. Gabi Hanna.

CLICK HERE to read the full story from Cleveland.com.

READ MORE

04/14/2026

Crain’s Cleveland Business: Former FDA leader appointed to Lamassu Biotech board of directors

A former executive at the U.S. Food and Drug Administration has been named to a Cleveland biotech company’s board of directors. Dr. Stephen Hahn, the 24th Commissioner of Food and Drugs, has been named a board member of Lamassu Biotech,...

READ THE ARTICLE
01/08/2026

RBV Quarterly: CEO Insights: Dr Gabi Hanna, Lamassu Biotech

Doctor Gabi Hanna’s journey from Qamishli, in north-west Syria, to leading Lamassu Biotech, a cutting-edge biopharmaceutical company in the United States, is a study in purpose, reinvention, and strategic clarity. Growing up with limited professional pathways, he chose medicine as...

READ THE ARTICLE
10/27/2025

Crain’s Cleveland Business: Notable Leaders in Health Care Technology 2025

Health care technology is rapidly transforming how we prevent, diagnose and treat disease, and Northeast Ohio is at the forefront of this evolution. Read Crain's full feature, which includes Lamassu Biotech CEO Dr. Gabi Hanna and Co-Founder Dr. Rabi Hanna.

READ THE ARTICLE